Harsh Patel, Ph.D., joined the Laboratory of Translational Genomics (LTG) as a postdoctoral fellow in the laboratory of Jiyeon Choi, Ph.D., M.S., Earl Stadtman Investigator, in 2020. Dr. Patel earned his Ph.D. in pharmacology from the State University of New York Upstate Medical University, Syracuse, and his M.S. in pharmacology and toxicology from the National Institute of Pharmaceutical Education and Research (NIPER – S.A.S. Nagar), India. Working with Dr. Ying Huang, his doctoral research was focused on investigating the regulatory mechanism and function of the ECRG2 tumor suppressor in the context of DNA damage-induced stress and microtubule dynamics. For his master’s research, he investigated the molecular mechanism of the chemopreventive potential of calorie restriction (CR) and nordihydroguaiaretic acid (NDGA) in a chemically induced breast cancer model.
Dr. Patel works on functional characterization of the genes and molecular pathways associated with genetic variants that contribute to risk of melanoma and lung cancer development, under the mentorship of Dr. Choi.